100 related articles for article (PubMed ID: 27219867)
21. Structural Mechanism of Transcriptional Regulator NSD3 Recognition by the ET Domain of BRD4.
Zhang Q; Zeng L; Shen C; Ju Y; Konuma T; Zhao C; Vakoc CR; Zhou MM
Structure; 2016 Jul; 24(7):1201-8. PubMed ID: 27291650
[TBL] [Abstract][Full Text] [Related]
22. Development of 4,5-dihydro-benzodiazepinone derivatives as a new chemical series of BRD4 inhibitors.
Li J; Wang P; Zhou B; Shi J; Liu J; Li X; Fan L; Zheng Y; Ouyang L
Eur J Med Chem; 2016 Oct; 121():294-299. PubMed ID: 27266999
[TBL] [Abstract][Full Text] [Related]
23. BET bromodomain-mediated interaction between ERG and BRD4 promotes prostate cancer cell invasion.
Blee AM; Liu S; Wang L; Huang H
Oncotarget; 2016 Jun; 7(25):38319-38332. PubMed ID: 27223260
[TBL] [Abstract][Full Text] [Related]
24. GSK6853, a Chemical Probe for Inhibition of the BRPF1 Bromodomain.
Bamborough P; Barnett HA; Becher I; Bird MJ; Chung CW; Craggs PD; Demont EH; Diallo H; Fallon DJ; Gordon LJ; Grandi P; Hobbs CI; Hooper-Greenhill E; Jones EJ; Law RP; Le Gall A; Lugo D; Michon AM; Mitchell DJ; Prinjha RK; Sheppard RJ; Watson AJ; Watson RJ
ACS Med Chem Lett; 2016 Jun; 7(6):552-7. PubMed ID: 27326325
[TBL] [Abstract][Full Text] [Related]
25. The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer.
da Motta LL; Ledaki I; Purshouse K; Haider S; De Bastiani MA; Baban D; Morotti M; Steers G; Wigfield S; Bridges E; Li JL; Knapp S; Ebner D; Klamt F; Harris AL; McIntyre A
Oncogene; 2017 Jan; 36(1):122-132. PubMed ID: 27292261
[TBL] [Abstract][Full Text] [Related]
26. PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer.
Raina K; Lu J; Qian Y; Altieri M; Gordon D; Rossi AM; Wang J; Chen X; Dong H; Siu K; Winkler JD; Crew AP; Crews CM; Coleman KG
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7124-9. PubMed ID: 27274052
[TBL] [Abstract][Full Text] [Related]
27. BET Bromodomain as a Target of Epigenetic Therapy.
Noguchi-Yachide T
Chem Pharm Bull (Tokyo); 2016; 64(6):540-7. PubMed ID: 27250788
[TBL] [Abstract][Full Text] [Related]
28. Modulation of p300/CBP Acetylation of Nucleosomes by Bromodomain Ligand I-CBP112.
Zucconi BE; Luef B; Xu W; Henry RA; Nodelman IM; Bowman GD; Andrews AJ; Cole PA
Biochemistry; 2016 Jul; 55(27):3727-34. PubMed ID: 27332697
[TBL] [Abstract][Full Text] [Related]
29. Targeting BET bromodomain proteins in solid tumors.
Sahai V; Redig AJ; Collier KA; Eckerdt FD; Munshi HG
Oncotarget; 2016 Aug; 7(33):53997-54009. PubMed ID: 27283767
[TBL] [Abstract][Full Text] [Related]
30. Isoxazole-Derived Amino Acids are Bromodomain-Binding Acetyl-Lysine Mimics: Incorporation into Histone H4 Peptides and Histone H3.
Sekirnik Née Measures AR; Hewings DS; Theodoulou NH; Jursins L; Lewendon KR; Jennings LE; Rooney TP; Heightman TD; Conway SJ
Angew Chem Int Ed Engl; 2016 Jul; 55(29):8353-7. PubMed ID: 27264992
[TBL] [Abstract][Full Text] [Related]
31. BET inhibition as a new strategy for the treatment of gastric cancer.
Montenegro RC; Clark PG; Howarth A; Wan X; Ceroni A; Siejka P; Nunez-Alonso GA; Monteiro O; Rogers C; Gamble V; Burbano R; Brennan PE; Tallant C; Ebner D; Fedorov O; O'Neill E; Knapp S; Dixon D; Müller S
Oncotarget; 2016 Jul; 7(28):43997-44012. PubMed ID: 27259267
[TBL] [Abstract][Full Text] [Related]
32. Molecular Pathways: Targeting the PI3K Pathway in Cancer-BET Inhibitors to the Rescue.
Stratikopoulos EE; Parsons RE
Clin Cancer Res; 2016 Jun; 22(11):2605-10. PubMed ID: 27250929
[TBL] [Abstract][Full Text] [Related]
33. Bromodomain and extra-terminal (BET) family proteins: New therapeutic targets in major diseases.
Padmanabhan B; Mathur S; Manjula R; Tripathi S
J Biosci; 2016 Jun; 41(2):295-311. PubMed ID: 27240990
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of bromodomain-containing protein 9 for the prevention of epigenetically-defined drug resistance.
Crawford TD; Vartanian S; Côté A; Bellon S; Duplessis M; Flynn EM; Hewitt M; Huang HR; Kiefer JR; Murray J; Nasveschuk CG; Pardo E; Romero FA; Sandy P; Tang Y; Taylor AM; Tsui V; Wang J; Wang S; Zawadzke L; Albrecht BK; Magnuson SR; Cochran AG; Stokoe D
Bioorg Med Chem Lett; 2017 Aug; 27(15):3534-3541. PubMed ID: 28606761
[TBL] [Abstract][Full Text] [Related]
35. Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300.
Crawford TD; Romero FA; Lai KW; Tsui V; Taylor AM; de Leon Boenig G; Noland CL; Murray J; Ly J; Choo EF; Hunsaker TL; Chan EW; Merchant M; Kharbanda S; Gascoigne KE; Kaufman S; Beresini MH; Liao J; Liu W; Chen KX; Chen Z; Conery AR; Côté A; Jayaram H; Jiang Y; Kiefer JR; Kleinheinz T; Li Y; Maher J; Pardo E; Poy F; Spillane KL; Wang F; Wang J; Wei X; Xu Z; Xu Z; Yen I; Zawadzke L; Zhu X; Bellon S; Cummings R; Cochran AG; Albrecht BK; Magnuson S
J Med Chem; 2016 Dec; 59(23):10549-10563. PubMed ID: 27682507
[TBL] [Abstract][Full Text] [Related]
36. Genetic backgrounds and modifier genes of NTD mouse models: An opportunity for greater understanding of the multifactorial etiology of neural tube defects.
Leduc RY; Singh P; McDermid HE
Birth Defects Res; 2017 Jan; 109(2):140-152. PubMed ID: 27768235
[TBL] [Abstract][Full Text] [Related]
37. Structural Basis of Inhibitor Selectivity in the BRD7/9 Subfamily of Bromodomains.
Karim RM; Chan A; Zhu JY; Schönbrunn E
J Med Chem; 2020 Mar; 63(6):3227-3237. PubMed ID: 32091206
[TBL] [Abstract][Full Text] [Related]
38. Development of Potent Dual BET/HDAC Inhibitors via Pharmacophore Merging and Structure-Guided Optimization.
Bauer N; Balourdas DI; Schneider JR; Zhang X; Berger LM; Berger BT; Schwalm MP; Klopp NA; Siveke JT; Knapp S; Joerger AC
ACS Chem Biol; 2024 Feb; 19(2):266-279. PubMed ID: 38291964
[TBL] [Abstract][Full Text] [Related]
39. Reevaluation of bromodomain ligands targeting BAZ2A.
Cazzanelli G; Vedove AD; Parolin E; D'Agostino VG; Unzue A; Nevado C; Caflisch A; Lolli G
Protein Sci; 2023 Sep; 32(9):e4752. PubMed ID: 37574751
[TBL] [Abstract][Full Text] [Related]
40. Deciphering Selectivity Mechanism of BRD9 and TAF1(2) toward Inhibitors Based on Multiple Short Molecular Dynamics Simulations and MM-GBSA Calculations.
Wang L; Wang Y; Yu Y; Liu D; Zhao J; Zhang L
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]